ClinicalTrials.gg
Sign In

Liver Cirrhosis, Biliary clinical trials

The registry lists 214 studies for Liver Cirrhosis, Biliary across more than 10 countries. 48 are recruiting or about to start. 180 of them are mainly about Liver Cirrhosis, Biliary (how this is decided). Per ClinicalTrials.gov, last updated 2026-11-12.

Get an email when these change. Save the Liver Cirrhosis, Biliary studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Watch these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your saved searches, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your saved searches. Stop any time.

Status

Completed
96
Recruiting
34
Status unknown
25
Terminated
22
Active, not recruiting
16
Not yet recruiting
11

Phase

Phase 2
63
Phase 3
44
Phase 1
26
Phase 4
15
Early Phase 1
4

Where

United States
83
China
52
United Kingdom
41
Canada
39
Spain
32
Germany
32

Who runs them

Xijing Hospital of Digestive Diseases (12) · Intercept Pharmaceuticals (11) · Gilead Sciences (10) · GlaxoSmithKline (8) · Ipsen (8) · University of Alberta (7) · Mayo Clinic (7) · University of Aarhus (6)

What is being tested here

Drugs under test in Liver Cirrhosis, Biliary studies, those with the most open studies first. Medicines only given beside them are not counted. How drugs are counted

DrugOpenPhase 3All
Fenofibrate7913
Saroglitazar346
Ursodeoxycholic Acid336
Seladelpar259
Linerixibat137
Elifibranor145
Linafexor115
Nemolizumab101
Upadacitinib101
Nalmefene101

Drug classes tested here Corticosteroids 5 · Reverse transcriptase inhibitors 3

Coming up

20phase 3 studies under way
14studies finish main data collection within a year3 of them phase 3

Studies recruiting or running, from their records. “Main data collection” ends at the primary completion date, the sponsor’s own estimate, which often moves.

The 10 nearest, phase 3 first

Who these studies take

Of the 34 Liver Cirrhosis, Biliary studies recruiting now, 16 (47%) set no upper age limit and 11 (32%) stop at 75 or younger. 3 (9%) take children under 18. 1 (3%) are for women only and 0 (0%) for men only; 4 (12%) take healthy volunteers.

Recruiting studies that take each age, of 34
AgeWomenMen
103 (9%)2 (6%)
1833 (97%)32 (94%)
3034 (100%)33 (97%)
4034 (100%)33 (97%)
5034 (100%)33 (97%)
6534 (100%)33 (97%)
7531 (91%)30 (88%)
8519 (56%)18 (53%)

Across all 214 studies, recruiting or not: 45% stop at 75 or younger and 9% at 65; 6% take children; 2% are for women only and 1% for men only; 10% take healthy volunteers. From each study’s registry entry; the criteria on its page decide.

How long Liver Cirrhosis, Biliary studies take

Of 21 phase 2 interventional studies under Liver Cirrhosis, Biliary, half reached primary completion within 23 months of starting, counting those still running.

Start to primary completionEvery sponsorIndustryNon-industry
Phase 16 mo2–24 · 15 studies——
Phase 223 mo18–34 · 21 studies——

Each figure is the month by which half the studies had reached primary completion, with the range in which the middle half did. Studies still running count until their last registry update; studies that stopped early are left out. Phase 1 includes early phase 1; observational means prospective or not stated, as retrospective and cross-sectional studies date a window of data rather than a study. How these figures are worked out

What changed recently

From the registry's own updates since Oct 14, 2026.

Started recruiting2

Newly registered2

Studies

Recruiting first, then most recently updated. Showing 50 of 214. Browse all 214 → or search them.